E-mail us:
service@prospectnews.com
Or call: 212 374 2800
Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
Add to balance / Manage account
Not logged in
Prospect News home
>
Main news index
>
All issuers starting with I
>
Issuers starting with I, PP only
>
All stories on Icagen, Inc.
>
Stories on Icagen, Inc., PP only
Search again
Enter part or all of the issuer name:
Market:
All markets
No structured products
Bank loans
Canadian bonds
CLOs
Convertibles
Distressed debt
Emerging markets
High yield
Investment grade
Liability management
Municipals
PIPEs
Preferreds
Private placements
All leveraged markets
Structured products
Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each.
All others are $1.00 each. Headlines in
gray
are not currently covered by your subscription.
Icagen, Inc.
7/7/2016
PP
Icagen raises $1.15 million via private placement of 8% convertibles
2/6/2008
PP
New Issue: Icagen to exercise option to sell $10 million of shares to Pfizer
2/6/2008
PP
Market Commentary:
Icagen puts $10 million of stock to Pfizer; Bankers completes part one of sale; Pegasus, Strategic to place
8/14/2007
PP
New Issue: Icagen arranges $15 million stock purchase agreement with Pfizer
1/30/2007
PP
Market Commentary:
Xtreme Coil prices C$54.6 million stock offering; Open Range Energy arranges C$10 million issue
1/29/2007
PP
Market Commentary:
Icagen prepares to settle $21.87 million stock sale; StockerYale pockets $2.3 million from PIPE
1/29/2007
PP
New Issue: Icagen secures $21.87 million from private placement of stock
©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.
